title: A case of multiple immune toxicities from Ipilimumab and pembrolizumab treatment.
authors.affiliation: Department of Diabetes & Endocrinology, Royal Bournemouth Hospital, Castle Lanes East, Bournemouth, BH7 7DW, UK. doctormalikasif@gmail.com.
authors.forename: Malik Asif
authors.initials: MA
authors.lastname: Humayun
authors.affiliation: NHS Foundation Trust, Poole Hospital, Poole, UK.
authors.forename: Ruth
authors.initials: R
authors.lastname: Poole
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D000072659:Hypophysitis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary; D008875:Middle Aged; D012307:Risk Factors; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000074324:Ipilimumab; C582435:pembrolizumab